Modern Diagnostic IPO GMP Signals 12% Premium as Rs 37 Crore Issue Opens on BSE SME
The Modern Diagnostic IPO GMP has grabbed attention in India’s financial circles as the company’s Initial Public Offering opens for subscription with promising early signals. This small-cap healthcare listing has generated interest among investors seeking opportunities in the stock market and among those tracking IPO momentum and potential listing gains.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →